Blockade of MYCN in neuroblastoma |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2011 |
California |
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Role of Fetal Growth in Pediatric Rhabdomyosarcoma |
University of California Berkeley / Catherine Metayer, MD, PhD |
Epidemiology Grants |
2013 |
California |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).
|
University of California San Francisco / Michelle Hermiston, MD, PhD |
Young Investigator Grants |
2009 |
California |
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC) |
University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD |
Epidemiology Grants |
2016 |
California |
Development of a comprehensive liquid biopsy-based genomics platform for pediatric solid tumors |
Children’s Hospital Los Angeles / Jaclyn Biegel |
Catalyst Grants |
2023 |
California |